Embedded Files
PODIUM TALK
PODIUM TALK
USING REAL-WORLD EVIDENCE FOR HEALTH TECHNOLOGY ASSESSMENT SUBMISSIONS: LESSONS AND INSIGHTS FROM REVIEW OF NICE’S TECHNOLOGY ASSESSMENT REPORTS
USING REAL-WORLD EVIDENCE FOR HEALTH TECHNOLOGY ASSESSMENT SUBMISSIONS: LESSONS AND INSIGHTS FROM REVIEW OF NICE’S TECHNOLOGY ASSESSMENT REPORTS
Source: ISPOR Podium Presentation. Please contact for replays or questions or capabilities at info@novelhealthstrategies.com
Impact of ICER HTAs
Impact of ICER HTAs
NOVEL Health Strategies is sharing insights from 5 recent studies on impact of ICER HTA Assessments on Pricing, Access and Coverage
NOVEL Health Strategies is sharing insights from 5 recent studies on impact of ICER HTA Assessments on Pricing, Access and Coverage
Market Access Trends for Top 100 Selling Drugs
Market Access Trends for Top 100 Selling Drugs
This is a quick replay of PLATINUM AWARD winning presentation by NOVEL Health Strategies Team on market access trends for top 100 selling drugs.
This is a quick replay of PLATINUM AWARD winning presentation by NOVEL Health Strategies Team on market access trends for top 100 selling drugs.
Please contact for replays or questions or capabilities at info@novelhealthstrategies.com
Expanded Access Programs
Expanded Access Programs
NOVEL Health Strategies was invited by AMCP to deliver a talk on expanded access programs
NOVEL Health Strategies was invited by AMCP to deliver a talk on expanded access programs
Market Access Trends for HCV
Market Access Trends for HCV
NOVEL Health Strategies was selected by AMCP for a podium presentation on market access trends for HCV
NOVEL Health Strategies was selected by AMCP for a podium presentation on market access trends for HCV
Global Trends in Market Access and Reimbursement
Global Trends in Market Access and Reimbursement
NOVEL Health Strategies was invited by Ministry of Foreign Affairs, Denmark for presentation on global market access trends and case studies
NOVEL Health Strategies was invited by Ministry of Foreign Affairs, Denmark for presentation on global market access trends and case studies
Please contact for replays or questions or invitations info@novelhealthstrategies.com
NOVEL's Study Shows Biologics are Safe and Effective for Early Crohn's Disease
NOVEL's Study Shows Biologics are Safe and Effective for Early Crohn's Disease
New study by NOVEL Health Strategies, Abbvie and Mount Sinai presented at UEGW Barcelona 2019 (October 2019)
Meta-Analysis of Defibrotide Risk of Bleeding Adverse Events
Meta-Analysis of Defibrotide Risk of Bleeding Adverse Events
New study by NOVEL Health Strategies and Jazz Pharmaceuticals presented at ASH 2019 (December 2019)
Report abuse